Where does Novo Nordisk Health Care AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novo Nordisk Health Care AG ranks #10,121 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novo Nordisk Health Care AG hold?

Novo Nordisk Health Care AG holds 31 US utility patents granted between 2015 and 2024, spanning 9 technology areas.

What is Novo Nordisk Health Care AG's Innovation Score?

Novo Nordisk Health Care AG has an Innovation Score of 37.6 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Novo Nordisk Health Care AG focus on?

Novo Nordisk Health Care AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 22 patents, ranking #884 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Novo Nordisk Health Care AG's patent grant rate increasing or decreasing?

Novo Nordisk Health Care AG's recent grant velocity is -37% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Novo Nordisk Health Care AG's patents?

Novo Nordisk Health Care AG's patents average 12.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novo Nordisk Health Care AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novo Nordisk Health Care AG

USPTO PatentsView assignee record - 31 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novo ranks #10,121 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 9 technology areas.

#10,121
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.6/100): 12.3
avg claims per patent: -37%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10121 · Foreign Corporation #10,121 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #10,121/49,997
PHOTO-FINISH Nevermind Capital
CPC-NARROW A61P · 9 areas
INNOV-THIN 37.6/100
CLAIMS-RICH 12.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -37% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nevermind Capital LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novo’s 37.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (32%) Velocity 7.6 pts (20%) Breadth 10.6 pts (28%) Claim depth 7.4 pts (20%)

Qualcomm Incorporated · highest

85
Cosmo · near

38
Exemplis · near

38
Novo Nordisk Health… · this assignee

38
ShenZhen Goldsun… · near

38
Summit Glove · near

38
3D Lighting… · lowest

7

What this shows Novo's Innovation Score is 37.6/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novo?

Each dot is one of Novo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novo’s own 12.3 claims/patent is at or below the 18.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Novo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novo's grants concentrate

Novo Nordisk Health Care AG is a focused PatentsView assignee: 9 CPC subclasses with 71% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (9 grants) versus a trough of 1 in 2017. By volume, Novo sits between Nevermind Capital LLC and OCV Intellectual Capital, LLC.

Novo's three-year grant acceleration

Novo Nordisk Health Care AG shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nevermind Capital

31
Newleaf Symbiotics

31
Nordco

31
Norton Healthcare

31
Novus Internation…

31
Nytell Software

31
Octapharma

31
OCV Intellectual…

31
Novo Nordisk Heal… ◀

31

What this shows Novo holds 31 patents at rank #10,121, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novo

By rank, the assignees closest to #10,121 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Novo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Novo ranks #884 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

ShenZhen Goldsun Network Intelligence Technology Co., Ltd. 38 Exemplis LLC 38 Cosmo Technologies Ltd. 38 Summit Glove Inc. 38

Novo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Novo Nordisk Health Care AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	29.0%
2016	3	9.7%
2017	1	3.2%
2018	3	9.7%
2019	3	9.7%
2020	2	6.5%
2021	2	6.5%
2022	1	3.2%
2023	1	3.2%
2024	6	19.4%

Which technologies does Novo Nordisk Health Care AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 19

C07K - Peptides 14

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 12

C12Y - Enzymes 11

C07D - Heterocyclic Compounds 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Novo Nordisk Health Care AG's patent record in context - here's where to go next.

Novo Nordisk Health Care AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 71% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,121 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novo Nordisk Health Care AG against Nevermind Capital LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.